Opko Health Inc
About
Opko Health Inc (NASDAQ:OPK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
Apr 21 2026
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
Apr 8 2026
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
Feb 27 2026
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
Feb 26 2026
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Financials
Revenue
$606.88 M
Market Cap
$875.18 M
EPS
-0.30